Trevi Therapeutics Inc
TRVI
Market Cap$883.49M
Close$
$0.33
95.3% downside
Current Fair Value
95.3% downsideOvervalued by 95.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $883.49 Million |
|---|---|
| Enterprise Value | $767.93 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 0.59 |
| Outstanding Shares | 130,350,391 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -19.99 |
|---|---|
| PEG | 4842.55 |
| Price to Sales | - |
| Price to Book Ratio | 7.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -15.15 |
| Enterprise Value to Net Income | -17 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data